跳至主要内容
临床试验/CTRI/2025/12/099257
CTRI/2025/12/099257招募中3 期

Efficacy of Homoeopathic intervention Influenzinum 30 in preventing Influenza-like Illness (ILI) at urban slums of Delhi - cluster-randomized, double-blind, placebo-control trial.

Central Council for Research in Homoeopathy1 个研究点 分布在 1 个国家目标入组 10,000 人开始时间: 2025年12月25日最近更新:

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
10,000
试验地点
1

研究概览

简要总结

Influenza like Illness has risen exponentially over the last two decades and has accorded a huge burden on economy and health infrastructure of countries especially those that are developing. Due to its high population density, India has shown vulnerability for rapidly evolving micro-organisms such as Influenza. This cluster-randomized, double-blind, placebo-controlled trial aims to evaluate the efficacy of Influenzinum 30 in preventing influenza among residents of 20 urban slum clusters in Delhi. Participants will receive weekly doses of the intervention or placebo from January to March for two years, along with IEC materials. Primary outcome is incidence of Influenza. Secondary outcomes include incidence and severity of acute undifferentiated febrile illness and mean duration of illness. The study will generate robust clinical evidence on the preventive role of homeopathy against Influenza and other febrile illnesses.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
Participant and Investigator Blinded

入排标准

年龄范围
1.00 Year(s) 至 99.00 Year(s)(—)
性别
All

入选标准

  • Voluntary written informed consent by the family head.

排除标准

  • Pregnant women and lactating mother Infants below age of 1 year Individuals taking other preventive medicines for ILI.
  • Patients with malignancy, immunocompromised state, life threatening diseases, end stage diseases.
  • Symptoms of acute febrile illness/ influenza like illness at the time of enrolment.
  • Patient with symptoms of acute infectious illnesses at the time of enrolment.
  • Not willing to give written informed consent.

研究者

发起方
Central Council for Research in Homoeopathy
申办方类型
Government funding agency
责任方
Principal Investigator
主要研究者

Dr Debadatta Nayak

Central Council for Research in Homoeopathy

研究点 (1)

Loading locations...

相似试验

Homoeopathy in preventing Influenza like Illness | 临床试验